Biochemical Reagents
1-Octanol, 98% min., EMD, 500mL, MilliporeSigma™
CAS: 111-87-5 Formule moléculaire: C8H18O Poids moléculaire (g/mol): 130.23 Numéro MDL: MFCD00002988 Clé InChI: KBPLFHHGFOOTCA-UHFFFAOYSA-N Synonyme: 1-octanol,octanol,octyl alcohol,n-octanol,capryl alcohol,caprylic alcohol,n-octyl alcohol,heptyl carbinol,1-hydroxyoctane,primary octyl alcohol CID PubChem: 957 ChEBI: CHEBI:16188 Nom IUPAC: octan-1-ol SMILES: CCCCCCCCO
TraceCERT™ Verbenon, 2000 μg/mL, Certified Reference Material, MilliporeSigma™ Supelco™
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034. This CRM is traceable to the SI through a primary reference material from a NMI. Certified content incl. uncertainty and expiry date are stated on the enclosed certificate.
Formaldehyde in Water , MilliporeSigma™ Supelco™
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
TraceCERT™ Fumaric Acid Solution, Certified Reference Material, MilliporeSigma™ Supelco™
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034. This CRM is traceable to the SI through a primary reference material from a NMI. Certified content incl. uncertainty and expiry date are stated on the enclosed certificate.
Tranexamic Acid Impurity Standard, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
Lamivudine Impurity Standard, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
Dorzolamide Impurity D, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
Selectophore™ Oleic acid, ≥99.0%, MilliporeSigma™ Supelco™
Numéro MDL: MFCD00064242 Synonyme: cis-9-Octadecenoic acid; Elainic acid
TraceCERT™ Methyl Palmitate, Certified Reference Material, MilliporeSigma™ Supelco™
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034. This CRM is traceable to the SI through a primary reference material from a NMI. Certified content incl. uncertainty and expiry date are stated on the enclosed certificate.
D-Mannitol, ≥99.0% (sum of enantiomers, HPLC); ≥99.9999% (metals basis), MilliporeSigma™ Supelco™
Numéro MDL: MFCD00064287 Synonyme: Mannite
Fluvoxamine Maleate Impurity Standard, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
Uridine, Certified Reference Material, MilliporeSigma™ Supelco™
Pharmaceutical secondary standards for application in quality control. Provides pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Chenodeoxycholic Acid, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.